The structure of monoacylglycerol lipase from Bacillus sp. H257 reveals unexpected conservation of the cap architecture between bacterial and human enzymes  by Rengachari, Srinivasan et al.
Biochimica et Biophysica Acta 1821 (2012) 1012–1021
Contents lists available at SciVerse ScienceDirect
Biochimica et Biophysica Acta
j ourna l homepage: www.e lsev ie r .com/ locate /bba l ipThe structure of monoacylglycerol lipase from Bacillus sp. H257 reveals unexpected
conservation of the cap architecture between bacterial and human enzymes
Srinivasan Rengachari a, Gustavo A. Bezerra a, Lina Riegler-Berket a, Christian C. Gruber b, Christian Sturm a,
Ulrike Taschler a, Andras Boeszoermenyi a, Ingrid Dreveny c, Robert Zimmermann a,
Karl Gruber a, Monika Oberer a,⁎
a Institute of Molecular Biosciences, University of Graz, A‐8010 Graz, Austria
b ACIB GmbH, Petersgasse 14, A-8010 Graz, Austria
c School of Pharmacy, University of Nottingham, NG7 2RD, UKAbbreviations: MGL, monoacylglycerol lipase; bMGL
Bacillus sp. H257; hMGL, human monoacylglycerol lipas
ﬂuoride; SAXS, small angle X-ray scattering; RMSD, roo
PAGE, sodium dodecyl sulphate polyacrylamide gel electr
⁎ Corresponding author at: Institute of Molecular B
Humboldtstrasse 50/3, A-8010 Graz, Austria. Tel.: +43
380 9897.
E-mail address: m.oberer@uni-graz.at (M. Oberer).
1388-1981 © 2012 Elsevier B.V.
doi:10.1016/j.bbalip.2012.04.006
Open access under CC BYa b s t r a c ta r t i c l e i n f oArticle history:
Received 30 November 2011
Received in revised form 18 April 2012
Accepted 20 April 2012
Available online 27 April 2012
Keywords:
Monoacylglycerol lipase
Open conformation
Evolutionary conservation
X-ray crystallography
Molecular dynamics simulation
Small-angle X-ray scatteringMonoacylglycerol lipases (MGLs) catalyse the hydrolysis of monoacylglycerol into free fatty acid and
glycerol. MGLs have been identiﬁed throughout all genera of life and have adopted different substrate
speciﬁcities depending on their physiological role. In humans, MGL plays an integral part in lipid metabolism
affecting energy homeostasis, signalling processes and cancer cell progression. In bacteria, MGLs degrade
short-chain monoacylglycerols which are otherwise toxic to the organism. We report the crystal structures
of MGL from the bacterium Bacillus sp. H257 (bMGL) in its free form at 1.2 Å and in complex with
phenylmethylsulfonyl ﬂuoride at 1.8 Å resolution. In both structures, bMGL adopts an α/β hydrolase fold
with a cap in an open conformation. Access to the active site residues, which were unambiguously identiﬁed
from the protein structure, is facilitated by two different channels. The larger channel constitutes the highly
hydrophobic substrate binding pocket with enough room to accommodate monoacylglycerol. The other chan-
nel is rather small and resembles the proposed glycerol exit hole in human MGL. Molecular dynamics simula-
tion of bMGL yielded open and closed states of the entrance channel and the glycerol exit hole. Despite
differences in the number of residues, secondary structure elements, and low sequence identity in the cap re-
gion, this ﬁrst structure of a bacterial MGL reveals striking structural conservation of the overall cap architec-
ture in comparison with human MGL. Thus it provides insight into the structural conservation of the cap
amongst MGLs throughout evolution and provides a framework for rationalising substrate speciﬁcities in
each organism.
© 2012 Elsevier B.V. Open access under CC BY-NC-ND license.1. Introduction
Monoacylglycerol lipases (MGLs) were ﬁrst identiﬁed in rat adi-
pose tissue and catalyse the breakdown of monoacylglycerol (MG),
a metabolic extracellular and intracellular intermediate, into free
fatty acid (FA) and glycerol [1]. In mammals, extracellular sources of
MG are dietary lipids which get hydrolysed in the intestine and in plas-
ma. IntracellularMGs are derived from the hydrolysis of diacylglycerols
during the degradation of triacylglycerols and glycerophospholipids [2].
MGL has also been shown to hydrolyse 2-arachidonoylglycerol, an, monoacylglycerol lipase from
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-NC-ND license.important signalling molecule in the endocannabinoid metabolism of
the central nervous system [3]. The endocannabinoid system regulates
various physiological processes such as appetite, inﬂammation, pain
sensation, and memory [4–7]. Moreover, a role of MGL in the progres-
sion of melanoma, human breast, ovarian and colorectal cancer has
been identiﬁed [8,9]. Inhibition of MGL activity in these cancers shows
a marked suppression of cell proliferation which also renders MGL a
promising novel drug target for cancer treatment. Hence, MGL and its
inhibition are considered to be of high therapeutic relevance [10,11].
In bacteria, MGs have been reported to be highly toxic. Consequently,
MGs are often used as antimicrobial agents in the food industry, thera-
peutic, and pharmaceutical applications [12–14]. The antimicrobial ac-
tivities have been shown to vary with chain length and saturation of
MGs; saturated MGs with 10 or 12 carbon atoms in the chain were
shown to be most effective [13,15]. Thus, MGL is crucial for bacterial
survival.
MGLs are conserved across species with varying substrate speciﬁc-
ities. Orthologs from mouse [16–18] and bacteria (e.g. Pseudomonas
sp. LP7315 [19,20], Mycobacterium tuberculosis [21], Mycobacterium
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biochemically. Recently, YJU3p has been identiﬁed as the functional
ortholog of mammalian MGL in yeast [25]. Although YJU3p shares
only 24% sequence identity with human MGL (hMGL), it was shown
to degrade long-chain MGs with high speciﬁc activity exhibiting
Vmax and Km values similar to mammalian MGL [25]. The 250
amino acid MGL ortholog from the moderately thermophilic Bacillus
sp. H257 (also termed MGLP, UniProtKB accession code P82597)
shares only 17% sequence identity with hMGL. bMGL is very speciﬁc
for MG, especially 1-monolauroylglycerol, and does not show any ac-
tivity towards di- and triacylglycerols [24]. The speciﬁcity and high
catalytic rates for MG can be used as a tool for the quantiﬁcation of
MG in biological samples [26].
Members of the MGL family serve as an interesting model for evo-
lutionary studies due to the fact that these lipases from humans to
bacteria hydrolyse MG (albeit with quite different speciﬁcities with
respect to the fatty acid chain length) and that they share very low se-
quence identity. Recently, 3D structures of human MGL (hMGL) in
free form and in complex with inhibitors have been determined
[27–29]. In this study, we report the crystal structures of MGL from
Bacillus sp. H257 (bMGL) in its free form and in complex with the ir-
reversible inhibitor phenylmethanesulfonyl ﬂuoride (PMSF) at 1.2 Å
and 1.8 Å resolution, respectively. bMGL adopts an α/β hydrolase
fold and shows an open lid conformation in free as well as in com-
plexed form. We unambiguously identiﬁed the catalytic aspartate
and histidine residues, which complete the catalytic triad along
with the previously identiﬁed serine. The structure presents an op-
portunity to gain a better understanding of the reaction mechanism,
the substrate speciﬁcity and the structural conservation of MGLs. Un-
expectedly, we uncovered that the overall architecture of MGLs is
conserved from bacteria to mammals, despite the differences in the
number of residues within the cap region, their low sequence identi-
ty, and a different composition of secondary structure elements.
2. Material and methods
2.1. Cloning, expression, and puriﬁcation of MGL
The synthetic gene of bMGL cloned in pUC57 (ATG Biosynthetics,
Merzhausen, Germany) was excised with the restriction enzymes
NdeI and XhoI and ligated into vector pET28a(+) (Novagen, Merck,
Whitehouse Station, USA) to generate an N-terminal (His)6 tagged
protein using standard procedures. E. coli BL21 (DE3) cells harbouring
pET28a(+)-bMGL were grown in Luria–Bertani broth at 37 °C from
an overnight seed culture till they reached mid-log phase. Gene ex-
pression was induced using 0.5 mM IPTG at 37 °C for 4 h. The cells
were harvested and lysed by sonication in buffer A (20 mM Tris–HCl
pH 7.5, 100 mM NaCl). The lysate was centrifuged at 22,000×g for
30 min, and the soluble fraction was loaded onto a Ni-NTA agarose
resin column (Qiagen, Hilden, Germany). The protein was eluted
with 20 mM Tris–HCl pH 7.5, 100 mM NaCl and 250 mM imidazole,
and was dialyzed against the same buffer without imidazole. Subse-
quently the protein was concentrated and loaded onto a Superdex
200 column (GE Healthcare) in buffer A at a ﬂow rate of 0.5 mL/min.
The purity of the protein was examined using SDS‐PAGE, and the pro-
tein concentration was determined by UV spectroscopy.
2.2. Small angle X-ray scattering analysis (SAXS)
Data collection for the SAXS studies was performed using a wave-
length of 1.5 Å and a MAR Image Plate detector [345 mm] at beamline
X33 at the European Molecular Biology Laboratory (EMBL), Hamburg,
Germany. The distance between the sample and the detector was
2.7 m. The protein sample was measured at three different concentra-
tions, namely 10.2, 5.2, and 1.1 mg/mL in buffer A. Bovine serum albu-
min (BSA) at a concentration of 4.3 mg/mL was used as standardsolution. Data analysis was performed using the programme PRIMUS;
scattering from the buffer was subtracted as background from the
protein measurements [30]. Low and high concentration data were
merged for data analysis. The evaluation of the radius of gyration
(RG) and the forward scattering intensity (I(0)) was performed
using the Guinier approximation [31]. The pair distribution function
was calculated with GNOM [32,33]. Calculation of the theoretical
scattering curve from the atomic structure and the subsequent calcu-
lation of the pair distribution function were performed with CRYSOL
and GNOM, respectively [32–34].
2.3. Monoacylglycerol hydrolase activity assay
Monoacylglycerol hydrolase activity of bMGL was assayed using a
protocol described previously [25]. The assay was also used to test the
inhibition of bMGL by JZL184 [11], a speciﬁc inhibitor reported for
hMGL, and PMSF, a commonly known serine hydrolase inhibitor. A
concentration of 0.89 nM of bMGL, 10 μM of JZL184 and PMSF con-
centrations ranging from 40 μM to 200 μMwere tested for the inhibi-
tion of bMGL. MG hydrolysis was measured after incubation for
20 min at 37 °C in the presence of inhibitor.
2.4. Crystallisation and data collection
Crystallisation trials were performed using the sitting drop vapour
diffusion method in a 96-well plate at 20 °C by mixing equal volumes
(0.5 μL) of ~20 mg/mL bMGL in buffer A and reservoir solutions, re-
spectively. Well diffracting crystals were obtained without cleavage
of the His-tag. Crystals were obtained with conditions from a com-
mercial screen (Morpheus, Molecular Dimensions, Suffolk, UK) with
the reservoir solution containing 0.1 M MES/imidazole pH 6.5, 12.5%
w/v PEG 1000, 12.5% w/v PEG 3350, 12.5% v/v MPD, and 0.02 M
of monosaccharides (D-glucose, D-mannose, D-galactose, L-fructose,
D-xylose, and N-acetyl-D-glucosamine). No additional cryo-protectant
was necessary for ﬂash cooling the crystals in liquid nitrogen. A dataset
was collected to 1.2 Å resolution at the X06DA PXIII beamline of the
Swiss Light Source at the Paul Scherrer Institute (Villigen, Switzerland).
Data collection statistics are listed in Table 1. Crystals of bMGL were
soaked with a solution of 250 mM of the irreversible inhibitor PMSF
for 90 min. A dataset was collected to 1.8 Å resolution at the X13
beamline, EMBL outstation, DESY, Hamburg, Germany.
2.5. Structure determination and reﬁnement
The uncomplexed bMGL dataset (1.2 Å) was indexed and integrat-
ed using iMosﬂm [35] and scaled using Scala [36]. Molecular replace-
ment was carried out using the Balbes server [37]. A carboxylesterase
structure (PDB ID: 1R1D) from Bacillus stearothermophilus exhibiting
34% sequence identity to bMGL was used as the template. Model
building was performed using Arp/warp [38]. The model was sub-
jected to rigid body and restrained reﬁnement cycles using the pro-
gramme REFMAC5 followed by several iterative rounds of reﬁnement
using PHENIX [39,40]. There, water molecules were added and the
weights for the X-ray/stereochemistry and X-ray/ADP were optimised
resulting in the lowest Rfree value. B-factors of the atoms were reﬁned
anisotropically. COOT was used to manually adjust and monitor the
structure and the solvent, resulting in a ﬁnal model with an Rfactor
of 13.5% and an Rfree of 15.8% [41]. The MolProbity server was used
to validate the model [42]. All amino acids were found in the allowed
regions of the Ramachandran plot. In the ﬁnal structure, no electron
density was observed for residues Gly135, Gly136, Glu137, and
Gly250. No electron density was observed for the N-terminal His-tag,
the thrombin cleavage sequence and the linker region introduced
from the vector.
X-ray diffraction data of the MGL–PMSF complex were indexed
and integrated using iMosﬂm and scaled using Scala [35,36]. Rigid
Table 1
Statistics of X-ray data collection and structure reﬁnement.
Contents bMGL bMGL–PMSF
Data collection
Wavelength (Å) 1.0 0.81
Resolution (Å) 17.8–1.2 26.6–1.8
Space group P21 P21
Unit-cell parameters
a, b, c (Å)
β (°)
38.15, 71.21, 43.66
111.7
38.05, 70.69, 43.44
111.7
Total number of
reﬂections
249649 55676
Unique reﬂections 67545 17878
Rsym 0.065 (0.34) 0.057 (0.19)
Completeness (%) 99.8 (99.8) 96.2 (79.63)
Mean I/σ(I) 10.7 (3.4) 11.1 (4.9)
Multiplicity 3.7 (3.6) 3.1 (2.8)
Reﬁnement statistics
No. of protein atoms 1934 1902
No. of ligand and/or
heteroatoms
8 ((4R)-2-
methylpentane-2,4-diol)
18 (PMSF and (4R)-2-
methylpentane-2,4-diol)
No. of solvent
molecules
348 202
Rcryst 13.5% 15.8%
Rfree 15.8% 19.4%
Model geometry
RMSD bonds (Å) 0.007 0.013
RMSD angles (°) 1.271 1.051
Ramachandran distribution
Most favoured (%) 97.2 97.6
Additionally
allowed (%)
2.8 2.4
Outliers (%) 0.0 0.0
Crystal parameters and data collection statistics are derived from SCALA [36]. To calcu-
late Rfree, 5% of the reﬂections were excluded from the reﬁnement. Rsym is deﬁned as
Rsym=ΣhklΣi | Ii(hkl)− 〈I(hkl)〉 | /ΣhklΣiIi(hkl). Data in parentheses correspond to the
highest resolution shells.
1014 S. Rengachari et al. / Biochimica et Biophysica Acta 1821 (2012) 1012–1021body reﬁnement was carried out with PHENIX [40]. Reﬁnement and
validation were further carried out as described above. Already at
the initial stages of model building and reﬁnement, additional density
for PMSF was clearly visible in the Fo–Fc map. The Ramachandran plot
indicated 100% of the residues in the allowed regions. Figures
depicting the protein structure were generated using PyMol (DeLano
Scientiﬁc) unless stated otherwise [43].
2.6. Molecular dynamics simulations and access path analysis
The three missing residues, Gly135, Gly136, and Glu137, in the
crystal structure of bMGL were modelled and optimised in YASARA
(Fig. S6) [44]. pKa values and protonation states of the titratable
amino acids were calculated at pH 7 using TITRA employing the Tan-
ford–Kirkwood sphere model [45]. The GROMACS 4.5.3 software
package was used to perform molecular dynamics simulations and
equilibrations [46]. The structure was solvated with water inside a
cubic box with a length of 7.5 nm, and minimised and equilibrated
for 0.1 ns (NPT and NVT, respectively), with positions restraint on
all heavy atoms followed by ﬁve unrestrained simulations of about
100 ns with explicit solvent employing OPLS all-atom force ﬁeld and
the TIP3P water model [47,48]. The backbone RMSD was monitored
to ensure complete equilibration of the protein model. All calcula-
tions were carried out with a 2-fs time step, and long-range electro-
static interactions were computed using the particle mesh Ewald
method. All bonds in the system were constrained using the LINCS al-
gorithm. The neighbour list search was updated every 5 steps within
a 1.0 nm cut-off. Van der Waals interactions were computed with a
cut-off of 1.4 nm. The isotropic Parrinello–Rahman protocol was
used for pressure (1 bar), and the velocity-rescaling thermostat was
used for temperature coupling. The components of the system wereseparately coupled at 300 K with a coupling constant of 0.1 ps. Peri-
odic boundary conditions were applied in all three dimensions. Calcu-
lations were performed on 64-bit Linux 48-core nodes of an AMD
Magny-Cours cluster. Data analysis and image rendering were carried
out with standard tools provided within GROMACS and YASARA, re-
spectively [44,46]. The MOLE software package was used for ana-
lysing the access paths to the active site [49]. Standard VDW radii
were applied for all calculations.
Accession numbers: The coordinates and structure factors were
deposited in the Protein Data Bank (PDB ID: 3RM3 and 3RLI).
3. Results
3.1. MGL from Bacillus sp. H257 is a monomer in solution adopting an α/β
hydrolase fold with a partly ﬂexible cap region
The structure of bMGL (Fig. 1A) was determined from a monoclin-
ic crystal (space group P21) at a resolution of 1.2Å. Statistics of the
data collection and structure reﬁnement are shown in Table 1. One
molecule of bMGL with approximate dimensions of 48Å×32Å×44Å
was present in the asymmetric unit. The protein core adopts an α/β
hydrolase fold that deviates slightly from the canonical α/β hydrolase
fold (Fig. S1). The canonical fold is characterised by a central β-sheet,
i.e. a β-hairpin followed by a parallel six-stranded sheet, ﬂanked by
α-helices on both sides. The central β-sheet of bMGL, on the other
hand, lacks the ﬁrst strand of the β-hairpin and thus consists of only
seven β-strands. Similar deviations from the canonical α/β hydrolase
fold are not uncommon and include enzymes missing the complete β-
hairpin [50,51].
A striking feature in the structure of bMGL is the 45 amino acid cap
region (Ile119 to Thr164), a structural moiety observed in many α/β
hydrolases. It protrudes from the loop connecting β-strand 5 and α-
helix 4 of the core structure. The region consists of a small α-helix
(α-cap: Ala127-Ala130) and two short antiparallel β-strands
(Tyr141-Asp143; Lys161-Pro163) connected by linker regions. A
plot of Cα atom B-factors against the sequence indicates that a large
part of the cap region is ﬂexible and dynamic (Fig. 1B, Fig. S2). This
is also underlined by a lack of electron density for residues Gly135,
Gly136, and Glu137.
The monomeric state of the protein was conﬁrmed using small
angle X-ray scattering (SAXS). The molecular weight calculated
from SAXS data is 28.7kDa, which matches the theoretical molecular
weight (29.2kDa) for the monomeric protein. The scattering curve
and the distance distribution function (Fig. 2A, B) calculated for the
atomic model ﬁt the experimental data almost perfectly. The devia-
tion in the maximum distance (Dmax) between the calculated and
the experimental data could be due to differences in the hydration
shell or the fact that the N-terminal His-tag present in the protein is
missing in the X-ray structure used for calculation. The radii of gyra-
tion were calculated using GNOM and are in very good agreement
resulting in 19.2±0.0Å and 19.9±0.4Å for the theoretical and exper-
imental data, respectively [33].
3.2. Active site architecture, the substrate-binding pocket, and exit of
hydrolytic products
The crystal structure of bMGL shows the enzyme in an open con-
formation (Fig. 3A, B) as observed for hMGL [27,28]. The catalytic res-
idues are buried at the bottom of a ~22Å long channel, which leads
from the surface to the active site and thus keeps the active centre
away from a polar environment. The rim at the entrance of the chan-
nel has a diameter of ~12Å and is lined by hydrophobic side chains
mostly from the cap (Ile125, Ile128, Leu142, and Ile145) and Val198
from the core domain. The entrance is built mainly from hydrophobic
side chains of the α/β hydrolase core (Phe29, Met98, Ala122, Leu167,
Leu170, and Val198; Fig. S3). The lipophilic potential of bMGL was
BA
N
Ser97
Asp196 His226
N
C
C
Fig. 1. Overall structure of monoacylglycerol lipase (MGL) from Bacillus sp. H257. The α/β hydrolase core is coloured wheat brown, the cap region (Ile119–Thr164) is represented in
ruby red. A) The catalytic residues Ser97, Asp196, and His226 are represented as ball and sticks. The small α-helix in the cap region is labelled as α-cap; the letters N and C represent
the respective termini of the protein. B) Tube representation of bMGL in the same orientation with the ﬂexibility of individual residues indicated based on B-factor values.
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represented in colours ranging from red to blue, with red rep-
resenting hydrophobic regions and blue representing hydrophilic re-
gions of the protein. The residues lining the binding pocket leading to
the active site can be observed as a red patch, indicating the rich hy-
drophobic nature of the pocket (Fig. 3B). The bottom of the substrate-
binding pocket has a more polar nature with contributions from the
catalytic residues Ser97, His226, and main chain atoms of residues
from the core domain (e.g. Gly28, Phe29, Gly31, Thr32, Ser35,2A B
1.5
0.5
1
lo
g 
(I)
exp.Dmaxcalc.Dmax
0
0 0.05 0.1 0.15 0.2 0.25 0.3 0.35
-0.5
-1
Fig. 2. Small angle X-ray scattering (SAXS) measurement of bMGL in solution. A) The
theoretical scattering curve of the atomic model (black) shows a good ﬁt to the exper-
imental data (grey). B) Pair distribution functions estimated from the SAXS data (grey)
and calculated for the crystal structure (black).Met98, and Asp148; Fig. S3). Hydrophobic patches at the bottom of
the substrate-binding site are formed by the side chains of residues
Leu96, Ala122, Ala158, and Leu170. Based on sequence alignment,
Ser97 had been predicted earlier to be the nucleophile of the active
site [24]. From the crystal structure, we identiﬁed Asp196 and
His226 as the other two residues completing the catalytic triad
(Fig. 4A). Met98 and Phe29 form the oxyanion hole, which stabilises
the tetrahedral intermediate formed in the course of the MG hydroly-
sis reaction. Hydrogen bonds play an important role in stabilising the
integrity of the active site (Fig. 4B). The hydrogen atom of the back-
bone NH groups of Met98 and Phe29 form polar contacts with a
water molecule (termed W5). In the uncomplexed enzyme, this
water molecule also forms a hydrogen bond with the nucleophile
Ser97. A hydrogen bond is formed between OG of Ser97 and NE2 of
His226. Similarly, ND1 of His226 and OD2 of Asp196 share a hydrogen
bond. All these hydrogen bonds are involved in stabilising the active
conformation of the catalytic centre.
A pore is located in the cap region of the protein lined by main-
chain atoms of residues Ser147, Ile145, Ala158, and Thr159 and corre-
sponds to the proposed exit hole for glycerol to leave the active site in
human MGL (Fig. 3) [27]. Compared to the main entrance leading to-
wards the active site which has a minimal radius of 3.1 Å, the exit hole
radius is limited to approx. 1 Å (Fig. 3D). Therefore, only small mole-
cules are expected to pass through this pore. However, due to the fact
that it is located within the most ﬂexible region of the protein, the
pore geometry is expected to change during substrate binding and/
or cap movement.
3.3. bMGL inhibition and bMGL–PMSF complex
Inhibition studies were performed on bMGL using JZL184, a com-
pound reported to speciﬁcally inhibit hMGL and some commonly
known serine hydrolase inhibitors, including PMSF [11]. The com-
pound JZL184 did not inhibit bMGL (data not shown), whereas
Substrate 
binding pocket
Glycerol 
exit hole
B
Glycerol 
exit hole
A
DC
Fig. 3. Surface and access paths to the catalytic site of bMGL. A and B) Surface representations of the uncomplexed bMGL structure showing the substrate-binding pocket and the
glycerol exit hole in two different orientations. The colouring scheme represents the lipophilic potential: Regions coloured red are hydrophobic, blue are hydrophilic. A) Orientation
of the protein as in Fig. 1. B) Orientation of the protein after rotation of 55 and 87° along X and Y axes, respectively, for better visualisation of the substrate binding pocket. C) Access
paths to the active site of bMGL. The main active site channel is shown in blue, and the proposed glycerol exit hole is shown in green. Residues shown as red sticks are part of the
catalytic triad (orientation of the molecule similar to Fig. 3B). D) Radii proﬁle of the access paths of bMGL starting from the active site (Ser97) towards the protein surface.
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S4). Covalently bound PMSF did not change the overall structure of
bMGL. The RMSD value for 243 Cα atoms based on an alignment of
free and complex structure is 0.13 Å as calculated with Pymol [43].
Binding of PMSF resulted in the displacement of water molecule W5
observed in the uncomplexed structure (Fig. 4C). Hydrogen bonds
mediated by W5 were replaced by equivalent interactions of the
O2S oxygen atom of the sulphonic acid moiety in the PMSF molecule.
The phenyl moiety of the bound inhibitor is projecting towards the
entrance channel and forms hydrophobic contacts with Phe29,
Leu167, Leu170 and Val198. The atomic details of the PMSF interac-
tions at the active site are shown in Fig. 4D. No electron density was
observed for 6 residues: Met132 to Glu137 (Fig. S5A). The minimal
radius of the proposed glycerol exit channel in the bMGL-PMSF com-
plex is larger (1.9 Å) than in the uncomplexed bMGL structure
(Fig. 3D and S5B).
3.4. Molecular dynamics simulation shows open and closed states of the
entrance channel and the glycerol exit hole
Residues missing within the cap region of the experimentally de-
termined structure of bMGL were added by modelling (Fig. S6). Five
100ns molecular dynamics simulations of bMGL H257 solvated in ex-
plicit water starting from the open conformation were carried out to
study the behaviour of bMGL in free solution. In three of ﬁve cases,
the entrance to the active site remained open (Fig. 5A) similar to
hMGL in the open conformation (Fig. 5C). In two other cases, the en-
trance was covered by the cap protecting the entrance to the active
site. This yielded a closed conformation of bMGL similar to the recent-
ly described closed conformation of hMGL (Fig. 5B, D) [29]. The coreregion of bMGL in open and closed conformation showed a root
mean square deviation (RMSD) around 1 Å relative to the structure
in open conformation equilibrated in solution. The cap region showed
an increasing RMSD up to 4.5 Å, indicating a signiﬁcant structural
rearrangement (Fig. 6A). In contrast to a complete unfolding of the
cap, the observed decrease and increase of the initial cap RMSD (rel-
ative to the open conformation) and the ﬁnal cap RMSD (relative to
the closed conﬁrmation) respectively, is a strong indication for a di-
rected cap movement from the open to the closed state [53]. The ﬂex-
ibility of bMGL in solution was calculated using the root mean square
ﬂuctuations (RMSF) per residue (Fig. 6B). In addition to the N- and C-
terminal regions, the cap region from Ile119 to Thr164 had highest
ﬂexibility of the protein in good agreement with the crystallographic
B-factors (Fig. 1B, Fig. S2). The short helix α-cap of bMGL undergoes a
partial unfolding during the closing event with movements up to 7 Å,
as observed during simulations.
4. Discussion
4.1. Structural comparison of bacterial and human MGL
We performed a structural comparison of bMGL (250 aa) and
hMGL (303 aa, PDB ID: 3HJU) which both possess an α/β hydrolase
fold but share only 17% sequence identity. As shown in Fig. 7A,
there is a 14-residue difference in the N-terminus of bMGL compared
to hMGL in agreement with the fewer number of β-strands in the core
domain of bMGL. It should be noted that two 3D structures of hMGL
in open conformation were determined from an isoform with 313
amino acids (PDB ID: 3JWE, 3JW8), i.e. a 10 amino acids insertion at
the N-terminus. Hence, there is a discrepancy of 10 amino acids in
BHis226Asp196
Met98
Phe29W5
Ser97
Asp196
His226
Ser97
PMSF
Phe29
Met98
Ser97
Asp196
His226
D
PMSF
A
C
Fig. 4. Active site architecture of bMGL. A) The 2Fo–Fc sigma weighted electron density map (grey) is contoured at 1σ around the catalytic triad residues Ser97, Asp196 and His226
(violet sticks). B) The catalytic triad environment in the presence of a water molecule in the uncomplexed structure. H-bonds are depicted as dashed lines. The catalytic triad and
oxyanion hole residues are shown in violet. The water molecule (W5) mediating the polar contacts is depicted in cyan. C) Environment of the catalytic triad in the bMGL–PMSF
complex structure. H-bonds are depicted as dashed lines. The catalytic triad residues and oxyanion hole forming residues are shown in green. The phenyl group of the PMSF mol-
ecule covalently bound to Ser97 is represented in magenta. D) Depiction of atomic details of the interaction between bMGL and PMSF using LigPlot+ [60].
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open conformation (PDB ID: 3HJU) and closed conformation (PDB ID:
3PE6). Residues deﬁning the catalytic centre of the proteins are well
conserved. These include conservation of the canonical GXSXG con-
sensus sequence (GHSMG and GLSMG in hMGL and bMGL, respec-
tively) and of the catalytic aspartate and histidine residues. In
addition, the structural positions of oxyanion hole forming residues
(Ala51 and Met123in hMGL, Phe29 and Met98 in bMGL) are also con-
served in both enzymes (Fig. 7A and B). The RMSD for Cα atoms of
206 amino acids of the α/β hydrolase core domain of bMGL
(corresponding to Met1 to Pro118, and Ala165 to Gly250) in compar-
ison with hMGL is 1.1 Å.
Comparison of the cap regions of hMGL with bMGL shows intrigu-
ing similarities despite a sequence identity of only 13% for that region
(Fig. 7A, C). The 62-residue cap of hMGL has been described as U-
shaped structure and comprises of three helices connected by loop re-
gions [28]. The 45-amino acid cap of bMGL, however, harbours a short
helical turn and a short two-stranded antiparallel β-sheet connected
by linkers. Despite these differences, both proteins exhibit a similar
overall shape and arrangement in the cap region in the open confor-
mation [27,28]. Starting from β-strand 5 of bMGL, a loop and a short
helical region traverse on top of the α/β hydrolase core. For the fol-
lowing three residues (Gly135 to Glu137) no electron density was ob-
served (see Figs. 1A, 7A). However, comparison of hMGL and bMGL
shows that these missing residues in the cap region of bMGL would
ﬁt in a similar position as the ﬁrst cap helix of hMGL (Fig. 7C). The
rest of the bMGL cap extends as a ~30 Å long loop completely crossing
the α/β hydrolase core back and forth before re-joining the α-helix 4
of the core domain. Interestingly, amino acids at the N-terminal(residues Tyr141-Asp143) and C-terminal ends (Lys161-Pro163) of
this long loop form a short antiparallel β-sheet, thus bringing these
parts in very close spatial proximity. The corresponding cap region
of hMGL (Val170-Lys206) forms a loop of almost identical overall
shape, which also crosses the α/β hydrolase core twice. In human
MGL, two α helices (Asp180-Leu184 and Lys188-Ser196) are formed
within this large loop and can thus accommodate the ‘additional res-
idues’ of its amino acid sequence compared to that of bMGL. To date,
the only 3D structures of MGLs known are from human and Bacillus
sp. H257. Interestingly, the bMGL structure presented here reveals
that both lipases share the same cap architecture in the open confor-
mation. MGL structures from various other organisms will need to be
determined in order to discern whether this cap arrangement is a
typical feature of MGLs and whether it has been conserved through-
out evolution.
For humanMGL, it has been proposed that the ﬁrst helix of the cap
region (α4) helps the protein attach itself to the membrane of neuro-
nal cells [28]. Thereby, access to the substrate 2-AG is enabled, which
is derived from the degradation of membrane phospholipids [28]. In
bMGL, this region corresponds to a loop region, including the
unobserved residues of the cap. Interestingly, electron density for
α4 is also not observed in one of the monomers of the crystallograph-
ic dimer of hMGL complexed with the inhibitor SAR629 [27]. This
suggests that this region is also ﬂexible in human MGL. The proposed
membrane-binding helix of hMGL is amphipathic, whereas the
corresponding stretch in bMGL is composed of mainly small and
polar residues. It could be that the predominantly observed mem-
brane and lipid-droplet associated localisation of hMGL is inﬂuenced
by this helix, whereas the hydrophilic character of bMGL is inferred
bMGL open, (PDB: 3RM3) 
A
bMGL after MD Simulation for 100 ns
B
hMGL closed, (PDB: 3PE6)
D
hMGL open, (PDB: 3JW8)
C
Fig. 5. Surface representation of open and closed conformations of human and bacterial MGL. A) Crystal structure of bMGL in the open conformation. B) bMGL structure in the closed
conformation after a 100 ns unrestrained molecular dynamics simulation in explicit water. C) Crystal structure of hMGL in the open conformation and D) hMGL structure in the
closed conformation with inhibitor bound. Active site residues are shown in blue, cap regions are shown in magenta and green for bMGL and hMGL respectively. The circles
mark the entrance to the binding pocket.
1018 S. Rengachari et al. / Biochimica et Biophysica Acta 1821 (2012) 1012–1021by the lack of this corresponding amphipathic helix. These character-
istics suggest that the restraints on the evolution of the cap region in
MGLs are exerted largely by the overall cap architecture and by their
respective physiological role.
Recently, the 3D structure of hMGL in complex with a novel inhib-
itor termed ‘Compound 1’ ((2-cyclohexyl-1,3-benzoxazol-6-yl){3-[4-
(pyrimidin-2-yl)piperazin-1-yl]azetidin-1-yl}methanone) was solved
(PDB ID: 3PE6) [29]. This structure shows a rearrangement of the cap
region resulting in a closed conformation of the enzyme (Fig. 5D),
with the inhibitor spanning the entire substrate-binding pocketA
Fig. 6. Flexibility of individual residues in bMGL. A) Backbone root mean square deviation of
cap region relative to the open conformation is shown in black and relative to the closed c
line). B) Backbone root means square ﬂuctuations (RMSF) per residue of bMGL during a 90
with a dotted line.[29]. Helix α4 is shown to undergo an 8 Å movement through an ‘in-
ward coiling’ action and substantially occlude the entrance to the ac-
tive site. The proposed glycerol exit hole is also closed in this
conformation [29]. It is unknown at this stage whether the inhibitor
compound 1 triggered the conformational rearrangement of the
cap, especially since hMGL in complex with the inhibitor SAR629
shows an open conformation [27]. No correlation between the closing
of the cap and the observed open or closed states of the proposed
glycerol exit hole could be observed in our molecular dynamics calcu-
lations of bMGL: In one of the simulations, the glycerol exit holeB
bMGL H257 during a 90 ns molecular dynamics simulation. The backbone RMSD of the
onﬁrmation in light grey, the core region of the protein is shown in dark grey (bottom
ns molecular dynamics simulation. The cap region from Ile119 to Thr164 is indicated
BA
Glycerol
exit hole
Binding
pocket
C
Binding
pocket
Glycerol
exit hole
D
Fig. 7. Structural comparison of bacterial and human MGL. A) Structure based sequence alignment of bMGL and hMGL (PDB ID: 3HJU) using Dali [58]. Secondary structure elements
correspond to those observed in bMGL. β-strands and α-helices are depicted as red arrows and purple cylinders, respectively. Residues in blue correspond to the consensus G-X-S-
X-G motif, the catalytic Asp and His, and the oxyanion hole forming residues. Residues within the cap regions of bMGL and hMGL are coloured in red and green, respectively. The
proposed membrane binding helix α4 in the cap region of hMGL is shown as orange cylinder. B) Conservation of the catalytic triad evidenced by a structural superimposition. The
structure of bMGL is shown as wheat brown cartoon and that of hMGL (PDB ID: 3JW8) as green cartoon. bMGL catalytic residues (Ser97-Asp196-His226) and hMGL (PDB ID: 3JW8)
catalytic residues (Ser132-Asp249-His279) are shown as sticks in atomic colours. The substrate binding pocket and the proposed glycerol exit hole are indicated by arrows. C)
Structural superposition of the cap region from bMGL (ruby red) and hMGL (green; PDB ID: 3JW8) shows a conserved architecture. D) bMGL (wheat brown) complexed to
PMSF (blue) superimposed onto hMGL (green; PDB ID: 3JWE) complexed to SAR629 (orange). The cavity of bMGL as calculated by Casox is represented as a grey surface.
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of the open or closed state of the main entrance of the binding pocket
(Fig. S7). Due to the fact that the transition between two stable con-
formations in free solution is a very rare event, no statistical evalua-
tion of the equilibrium constant between the open and the closed
state can be conducted in this study. However, the observation of
two independent closing events within a total of 500 ns of simulation
clearly demonstrates that stable open and closed conformations of
bMGL can exist and that the transition between these two states
might be possible under physiological conditions even in the absence
of inhibitors.
The substrate speciﬁcity of α/β hydrolases is largely determined
by the cap region of the respective enzyme [50]. bMGL has been
reported to exert highest activity towards monolauroylglycerol
(C12:0) (121.1 μmol of released glycerol/min∗mg protein) and less ac-
tivity towards longer fatty acid chains as substrate e.g. mono-
oleoylglycerol (C18:1) (69.0 μmol of released glycerol/min∗mg
protein) [24]. The speciﬁc activity of mouse MGL towardsmonooleoylglycerol has been reported to be ~360 μmol of released
FA/min∗mg protein [16]. In accordance with the different substrate
preferences (long-chain MG vs. more water-soluble, short-chain
MGs), helix α4 and the corresponding more hydrophilic region of
bMGL could also aid in co-localising MGL at sites of high substrate
availability. Experimental 3D structures with bound substrates of
different chain lengths, which could give unambiguous insight into
residues participating in substrate selectivity, are currently
unknown. For hMGL, docking calculations have been performed to
understand the binding of 2-arachidonoylglycerol at the active site
[27,29]. Apart from the catalytically important residues, Tyr204 in
the cap region has been identiﬁed to stabilise the glycerol moiety of
MG bound to the active site. Structural comparison shows that
Glu156 could perform a similar role in bMGL.
Analysis of the binding pocket reveals differences between the
structures of bMGL and hMGL. The active site of bMGL is at the bot-
tom of a channel buried between the cap and the core region about
20 Å away from solvent. JZL184 is a speciﬁc inhibitor for hMGL and
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ture of hMGL in an open conformation [27]. JZL184 did not inhibit
bMGL in our inhibition studies. Structural analysis of the substrate-
binding pockets of bMGL and hMGL using the programme Casox sug-
gests that hMGL possesses a larger binding cavity than bMGL (Fig. 7D)
[52]. JZL184 might not be able to enter the narrower cavity of bMGL
or bMGL might not be able to accommodate the two aromatic substit-
uents of the inhibitor JZL184 in the same conformation as observed
for SAR629 in the human structure. This provides a rationale for the
inability of JZL184 to inhibit bMGL. The binding pocket of bMGL ap-
pears to be favourable for the binding of smaller MGs, whereas in
the human enzyme, a rather large pocket would enable binding of
longer MGs, which constitute the majority of available MG substrates.
hMGL has been shown to be inhibited by compounds which inter-
act with cysteine residues [54]; hMGL has four cysteines, two of
which (Cys201 and Cys242) are close to the catalytic centre and
have been shown to interact with the reported isothiazolinone-
based compound. bMGL also contains four cysteines, however, none
of those have a positional conservation with hMGL and are spatially
very distant from the site of catalysis.
4.2. Structural basis for thermostability of bMGL
bMGL was described as a moderately thermophilic protein and
was biochemically characterised at 65 °C. We compared both struc-
tures to discover cues describing the structural basis of thermostabil-
ity based on amino acid composition, salt bridges and cation-π
interactions [55]. The bMGL structure shows that 16/250 residues
(6.4%) form surface salt bridges whereas in hMGL (303aa isoform)
17/303 residues (5.6%) form salt bridges [56]. Two pairs of residues
are involved in forming cation-π interaction in both bMGL (Arg87:
Trp83 and Lys216:Phe208) and hMGL (Arg196:Tyr278 and Arg303:
Trp299) [57]. Accordingly, bMGL has one cation-π interaction for
every 125 residues whereas hMGL possesses one per 156 residues.
An increase in the number of Arg, Glu, Pro, and Tyr residues accompa-
nied by decrease in Ala, Asn, Gln, Leu, Ser, and Thr is also reported to
contribute to the thermostability of proteins [55]. bMGL indeed
shows a modest increase in the number of Glu and Tyr residues ac-
companied by a decrease of Asn, Gln, Leu and Ser residues. Taken to-
gether, all these individual factors could contribute to the increased
thermostability of bMGL compared to hMGL.
4.3. Evolutionary conservation of MGL
The functional conservation combined with the variation in sub-
strate speciﬁcity and low sequence identity across species makes
MGL an excellent model for studying protein evolution through 3D
structures. The 3D structures of hMGL and bMGL exhibit a high con-
servation of the fold despite very low sequence identity. A Dali search
using the bMGL structure identiﬁed many other α/β hydrolases with
the same core structure [58]. Somewhat similar cap architectures
were observed in the feruloyl esterase (PDB ID: 2WTN; Z-score:
24.5, RMSD: 2.6 Å) and two other proteins (PDB ID: 3LLC; Z-score:
21.8, RMSD: 2.6 Å and 2HDW; Z-score: 21.6, RMSD: 3.0 Å) which
are not yet biochemically characterised [59]. A multiple sequence
alignment of MGLs from various species also shows that this enzyme
class has a low overall degree of sequence conservation apart from
the signature lipase motifs and the catalytic residues (Fig. S8). Inter-
estingly, this analysis shows that hMGL shares a higher sequence
identity with some MGL from bacteria (e.g.M. tuberculosis) compared
to MGLs from plants and yeast. While the yeast ortholog YJU3p shares
a mere 24% sequence identity with hMGL, reports suggest that the
gene product of Rv0183 (33% sequence identity to hMGL) of the M.
tuberculosis H37Rv strain is the closest known unicellular ortholog
of hMGL. The mycobacterial enzyme is reported to be responsible
for the degradation of cellular lipids of infected humans and hasbeen shown to possess unaltered speciﬁcity towards both, 1-
monolauroylglycerol (C12:0) and 1-monooleoyl glycerol (C18:1) [21].
In light of the here presented 3D structure of bMGL and the observed
conservation of the cap architecture between human and bacterial
MGLs, it is tempting to speculate a very similar structural architecture
of the cap of the mycobacterial enzyme with secondary structure ele-
ments closely resembling those of human MGL.
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